Literature DB >> 24741089

Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.

Miriam Schieffer1, Heiko K Jessen2, Alexander F Oster3, Franco Pissani3, Damien Z Soghoian4, Richard Lu3, Arne B Jessen2, Carmen Zedlack2, Bruce T Schultz3, Isaiah Davis2, Srinika Ranasinghe4, Eric S Rosenberg5, Galit Alter4, Ralf R Schumann6, Hendrik Streeck7.   

Abstract

UNLABELLED: Effector CD4 T cell responses have been shown to be critically involved in the containment and clearance of viral pathogens. However, their involvement in the pathogenesis of HIV infection is less clear, given their additional role as preferred viral targets. We previously demonstrated that the presence of HIV-specific CD4 T cell responses is somewhat associated with HIV control and that specific CD4 T cell functions, such as direct cytolytic activity, can contribute to control of HIV viremia. However, little is known about how the induction of HIV-specific CD4 T cell responses during acute HIV infection influences disease progression and whether responses induced during the early phase of infection are preferentially depleted. We therefore longitudinally assessed, in a cohort of 55 acutely HIV-infected individuals, HIV-specific CD4 T cell responses from acute to chronic infection. Interestingly, we found that the breadth, magnitude, and protein dominance of HIV-specific CD4 T cell responses remained remarkably stable over time. Moreover, we found that the epitopes targeted at a high frequency in acute HIV infection were recognized at the same frequency by HIV-specific CD4 T cells in chronic HIV infection. Interestingly the induction of Gag-specific CD4 T cell responses in acute HIV infection was significantly inversely correlated with viral set point in chronic HIV infection (R = -0.5; P = 0.03), while the cumulative contribution of Env-specific CD4 T cell responses showed the reverse effect. Moreover, individuals with HIV-specific CD4 T cell responses dominantly targeting Gag over Env in acute HIV infection remained off antiretroviral therapy significantly longer (P = 0.03; log rank). Thus, our data suggest that the induction of HIV-specific CD4 T cell responses during acute HIV infection is beneficial overall and does not fuel disease progression. IMPORTANCE: CD4 T cells are critical for the clearance and control of viral infections. However, HIV preferentially infects HIV-specific CD4 T cells. Thus, their contribution to the control of HIV viremia is uncertain. Here, we study HIV-specific CD4 T cell responses from acute to chronic HIV infection and show that the generation of certain CD4 responses is associated with control rather than disease progression.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24741089      PMCID: PMC4054446          DOI: 10.1128/JVI.00728-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.

Authors:  Marcus Altfeld; Todd M Allen; Xu G Yu; Mary N Johnston; Deepak Agrawal; Bette T Korber; David C Montefiori; David H O'Connor; Ben T Davis; Paul K Lee; Erica L Maier; Jason Harlow; Philip J R Goulder; Christian Brander; Eric S Rosenberg; Bruce D Walker
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

2.  Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.

Authors:  A Oxenius; S Fidler; M Brady; S J Dawson; K Ruth; P J Easterbrook; J N Weber; R E Phillips; D A Price
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

3.  HIV preferentially infects HIV-specific CD4+ T cells.

Authors:  Daniel C Douek; Jason M Brenchley; Michael R Betts; David R Ambrozak; Brenna J Hill; Yukari Okamoto; Joseph P Casazza; Janaki Kuruppu; Kevin Kunstman; Steven Wolinsky; Zvi Grossman; Mark Dybul; Annette Oxenius; David A Price; Mark Connors; Richard A Koup
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

4.  Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

Authors:  R H Lyles; A Muñoz; T E Yamashita; H Bazmi; R Detels; C R Rinaldo; J B Margolick; J P Phair; J W Mellors
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

Review 5.  Harnessing CD4⁺ T cell responses in HIV vaccine development.

Authors:  Hendrik Streeck; M Patricia D'Souza; Dan R Littman; Shane Crotty
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

6.  Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope.

Authors:  Ryusuke Omiya; Chantal Buteau; Hiroya Kobayashi; Carlos V Paya; Esteban Celis
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

Authors:  Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

8.  Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.

Authors:  Uma Malhotra; Sarah Holte; Tuofu Zhu; Elizabeth Delpit; Claire Huntsberry; Alessandro Sette; Raj Shankarappa; Janine Maenza; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control.

Authors:  Srinika Ranasinghe; Sam Cutler; Isaiah Davis; Richard Lu; Damien Z Soghoian; Ying Qi; John Sidney; Gregory Kranias; Michael D Flanders; Madelene Lindqvist; Bjorn Kuhl; Galit Alter; Steven G Deeks; Bruce D Walker; Xiaojiang Gao; Alessandro Sette; Mary Carrington; Hendrik Streeck
Journal:  Nat Med       Date:  2013-06-23       Impact factor: 53.440

10.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

View more
  26 in total

1.  Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load.

Authors:  Omolara Baiyegunhi; Bongiwe Ndlovu; Funsho Ogunshola; Nasreen Ismail; Bruce D Walker; Thumbi Ndung'u; Zaza M Ndhlovu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

2.  Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.

Authors:  Asli Bauer; Lilli Podola; Philipp Mann; Marco Missanga; Antelmo Haule; Lwitiho Sudi; Charlotta Nilsson; Bahati Kaluwa; Cornelia Lueer; Maria Mwakatima; Patricia J Munseri; Leonard Maboko; Merlin L Robb; Sodsai Tovanabutra; Gustavo Kijak; Mary Marovich; Sheena McCormack; Sarah Joseph; Eligius Lyamuya; Britta Wahren; Eric Sandström; Gunnel Biberfeld; Michael Hoelscher; Muhammad Bakari; Arne Kroidl; Christof Geldmacher
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

Review 3.  Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.

Authors:  George K Lewis; Anthony L DeVico; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

4.  HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer+ Gag-Specific CD4+ T Cells in Chronic Clade C HIV-1 Infection.

Authors:  Faatima Laher; Srinika Ranasinghe; Filippos Porichis; Nikoshia Mewalal; Karyn Pretorius; Nasreen Ismail; Søren Buus; Anette Stryhn; Mary Carrington; Bruce D Walker; Thumbi Ndung'u; Zaza M Ndhlovu
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

5.  Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.

Authors:  Kazutaka Terahara; Hiroshi Ishii; Takushi Nomura; Naofumi Takahashi; Akiko Takeda; Teiichiro Shiino; Yasuko Tsunetsugu-Yokota; Tetsuro Matano
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 6.  Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?

Authors:  Bernard J C Macatangay; Charles R Rinaldo
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

7.  HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses.

Authors:  Srinika Ranasinghe; Damien Z Soghoian; Madelene Lindqvist; Musie Ghebremichael; Faith Donaghey; Mary Carrington; Michael S Seaman; Daniel E Kaufmann; Bruce D Walker; Filippos Porichis
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

8.  Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome.

Authors:  Hendrik Streeck; Richard Lu; Noor Beckwith; Mark Milazzo; Michelle Liu; Jean-Pierre Routy; Susan Little; Heiko Jessen; Anthony D Kelleher; Frederick Hecht; Rafick-Pierre Sekaly; Galit Alter; David Heckerman; Mary Carrington; Eric S Rosenberg; Marcus Altfeld
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

9.  Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children.

Authors:  Stefano Rinaldi; Suresh Pallikkuth; Mark Cameron; Lesley R de Armas; Nicola Cotugno; Vinh Dinh; Rajendra Pahwa; Brian Richardson; Shelly R Saini; Salvatore Rocca; Maria G Lain; Sion L Williams; Paolo Palma; Savita Pahwa
Journal:  J Immunol       Date:  2019-12-30       Impact factor: 5.422

10.  Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.

Authors:  Evan S Jacobs; Sheila M Keating; Mohamed Abdel-Mohsen; Stuart L Gibb; John W Heitman; Heather C Inglis; Jeffrey N Martin; Jinbing Zhang; Zhanna Kaidarova; Xutao Deng; Shiquan Wu; Kathryn Anastos; Howard Crystal; Maria C Villacres; Mary Young; Ruth M Greenblatt; Alan L Landay; Stephen J Gange; Steven G Deeks; Elizabeth T Golub; Satish K Pillai; Philip J Norris
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.